Equipping Clinicians to Manage and Overcome Potential Complications of CAR T-Cell Therapy

Review the latest multidisciplinary guidance on monitoring and managing toxicities associated with CAR T-cell therapy. This comprehensive program features an expert-authored commentary and MedicalMinute slide/audio presentations, a pocket guide, and an updated online Interactive Decision Support Tool.

Alix Beaupierre, BSN, RN, OCN

Daniel J. DeAngelo, MD, PhD

Matthew J. Frigault, MD

Shilpa Paul, PharmD, BCOP

Noopur Raje, MD

Interactive Decision Support Tool

Decision Tool

An Interactive Algorithm Tool: Assessment and Management of CAR T-Cell Toxicities

View Decision Tool

Use this Interactive Decision Support Tool to obtain strategies to assess and manage CAR T-cell therapy–associated toxicities from 5 renowned multidisciplinary experts.

Alix Beaupierre, BSN, RN, OCN

Daniel J. DeAngelo, MD, PhD

Matthew J. Frigault, MD

Shilpa Paul, PharmD, BCOP

Noopur Raje, MD Released: July 9, 2021